콘드로이틴 황산 시장 : 기회, 성장 요인, 산업 동향 분석 및 예측(2026-2035년)

The Global Chondroitin Sulphate Market was valued at USD 1.5 billion in 2025 and is estimated to grow at a CAGR of 5.3% to reach USD 2.4 billion by 2035.

The market is gaining steady momentum as awareness around joint health continues to rise among aging populations and health-focused consumers worldwide. The increasing incidence of joint discomfort and mobility-related conditions is encouraging greater consumption of nutritional supplements and functional products formulated with chondroitin sulphate. The market is also benefiting from shifting consumer preferences toward naturally derived and responsibly sourced ingredients, reinforcing demand for high-quality formulations. Advancements in production methods are improving purity, consistency, and scalability while supporting sustainability goals. Growth in the companion animal and livestock wellness space is further expanding application scope, as joint-support formulations gain importance in pet nutrition. Digital retail channels are strengthening market access, enabling brands to reach a broader consumer base while offering product transparency and convenience. Collectively, these dynamics are reinforcing long-term demand for chondroitin sulphate across human nutrition, veterinary applications, and wellness-focused product categories.

The bovine-based chondroitin sulphate segment accounted for 39.3% share in 2025. This source continues to see widespread use due to its strong functional performance in joint health formulations and its established presence across supplement manufacturing.

The powdered chondroitin sulphate segment held 55.9% share in 2025. The dominance of this form is supported by its formulation flexibility, ease of incorporation into supplements, and alignment with clean-label and customizable nutrition trends.

North America Chondroitin Sulphate Market held 38.2% share in 2025. The region continues to show strong demand driven by high consumer awareness of joint health, widespread supplement usage, and a mature nutraceutical industry. The United States remains the primary contributor, supported by a strong preference for transparent sourcing and quality-focused formulations.

Key companies active in the Global Chondroitin Sulphate Market include Wanbury Limited, TSI Group Ltd., ZPD A/S, Sierra Ingredients Pty Ltd., Synutra Ingredients (Shandong) Co., Ltd., Pacific Rainbow International, Inc., Guangdong Hybribio Biotech Co., Ltd., Yantai Dongcheng Pharmaceutical Group Co., Ltd., Shandong Runxin Biotechnology Co., Ltd., Jiaxing Hengjie Biopharmaceutical Co., Ltd., BGM Pharmaceuticals Co., Ltd., Qufu Liyang Biochem Industrial Co., Ltd., YBCC (Qingdao) Co., Ltd., and Anhui Jintung Fine Chemical Corporation Ltd. Companies operating in the Global Chondroitin Sulphate Market are focusing on quality enhancement, supply chain transparency, and product differentiation to strengthen their market position. Manufacturers are investing in advanced processing technologies to improve purity, consistency, and sustainability while meeting evolving regulatory standards. Strategic partnerships with supplement brands and distributors are expanding global reach and application diversity. Firms are also prioritizing clean-label positioning and traceability to align with consumer demand for ethically sourced ingredients.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Source
  • 2.2.3 Form
  • 2.2.4 Application
  • 2.2.5 Distribution Channel
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: Strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future Outlook and Strategic Recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
  • 3.2.2 Industry pitfalls and challenges
  • 3.2.3 Market opportunities
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Price trends
• 3.8 Future market trends
• 3.9 Technology and Innovation landscape
  • 3.9.1 Current technological trends
  • 3.9.2 Emerging technologies
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New Product Launches
  • 4.6.4 Expansion Plans

Chapter 5 Market Estimates and Forecast, By Source, 2022-2035 (USD Million & Tons)

• 5.1 Key trends
• 5.2 Bovine
• 5.3 Porcine
• 5.4 Avian
  • 5.4.1 Chicken
  • 5.4.2 Turkey
  • 5.4.3 Others
• 5.5 Marine
  • 5.5.1 Tuna
  • 5.5.2 Salmon
  • 5.5.3 Others
• 5.6 Others

Chapter 6 Market Estimates and Forecast, By Form, 2022-2035 (USD Million & Tons)

• 6.1 Key trends
• 6.2 Powder
• 6.3 Capsule/Tablets
• 6.4 Liquid

Chapter 7 Market Estimates and Forecast, By Application, 2022-2035 (USD Million & Tons)

• 7.1 Key trends
• 7.2 Dietary Supplements
  • 7.2.1 Capsules
  • 7.2.2 Tablets
  • 7.2.3 Gummies
• 7.3 Pharmaceuticals
  • 7.3.1 Osteoarthritis treatment drugs
  • 7.3.2 Joint health formulations
• 7.4 Cosmetic and Personal Care
  • 7.4.1 Anti-aging creams
  • 7.4.2 Skin hydration products
• 7.5 Food and Beverages
• 7.6 Others

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2022-2035 (USD Million & Tons)

• 8.1 Key trends
• 8.2 Direct Sales
• 8.3 Distributors
• 8.4 Online Retail
• 8.5 Pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2022-2035 (USD Million & Tons)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 TSI Group Ltd.
• 10.2 Synutra Ingredients (Shandong) Co., Ltd.
• 10.3 Yantai Dongcheng Pharmaceutical Group Co., Ltd.
• 10.4 Jiaxing Hengjie Biopharmaceutical Co., Ltd.
• 10.5 Qufu Liyang Biochem Industrial Co., Ltd.
• 10.6 Pacific Rainbow International, Inc.
• 10.7 Shandong Runxin Biotechnology Co., Ltd.
• 10.8 ZPD A/S
• 10.9 Guangdong Hybribio Biotech Co., Ltd.
• 10.10 Wanbury Limited
• 10.11 Sierra Ingredients Pty Ltd.
• 10.12 BGM Pharmaceuticals Co., Ltd.
• 10.13 YBCC (Qingdao) Co., Ltd.
• 10.14 Anhui Jintung Fine Chemical Corporation Ltd.